Showing results (1711-1720 of 2,022) with videos related to

Sort By:
Pageof 203
Physical Review Letters|December 21, 2011
High-gain harmonic-generation free-electron laser seeded by harmonics generated in gasM Labat, M Bellaveglia, M Bougeard, et al.
Nature Communications|March 23, 2023
Assessment of community efforts to advance network-based prediction of protein-protein interactionsXu-Wen Wang, Lorenzo Madeddu, Kerstin Spirohn, et al.
Frontiers in Oncology|November 15, 2021
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre StudyAlessandro Parisi, Alessio Cortellini, Olga Venditti, et al.
BMC Cancer|September 11, 2019
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocolAlessandro Ottaiano, Stefania Scala, Nicola Normanno, et al.
Therapeutic Advances in Medical Oncology|April 15, 2021
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocolAlessandro Ottaiano, Stefania Scala, Mariachiara Santorsola, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 1, 2024
Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomesIlaria Cuccu, Francesco Raspagliesi, Mario Malzoni, et al.
Thyroid : Official Journal of the American Thyroid Association|September 20, 2021
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4)Raffaella Forleo, Giorgio Grani, Marco Alfò, et al.
F1000Research|July 20, 2022
A roadmap for the generation of benchmarking resources for antimicrobial resistance detection using next generation sequencingMauro Petrillo, Marco Fabbri, Dafni Maria Kagkli, et al.
BMC Cancer|February 10, 2016
A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme)Antonio Avallone, Maria Carmela Piccirillo, Luigi Aloj, et al.
Neuromuscular Disorders : NMD|November 10, 2019
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE studyDarryl C De Vivo, Enrico Bertini, Kathryn J Swoboda, et al.
Pageof 203